Wen LI, Junli YANG, Dong ZHOU, Jinghui ZHANG, Qingcui ZHUO
BIOCELL, Vol.43, No.1, pp. 7-12, 2019, DOI:10.32604/biocell.2019.04763
Abstract The efficacy and safety of ganglioside in the treatment of neonates who suffer from hypoxic–ischemic
encephalopathy (HIE) needs to be fully evaluated. We searched the following databases: PubMed, ScienceDirect,
LISTA, CNKI, Chinese biomedical literature database and Wanfang digital journals of full-text database to determine
the inclusion and exclusion criteria of papers and a total of 12 papers were included after quality evaluation. Then we
conducted the meta-analysis with RevMan5.0 software. The results showed that compared with the control group, the
abnormal rate declined in the ganglioside-treated group (relative risk (RR)=0.27, 95% confidence interval (CI)= 0.05– More >
Login
Register
